New Trial Shows Effectiveness of BPaL Regimen for Highly Drug-Resistant TB

TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure to the drug linezolid. Read Here.

19 views0 comments

Recent Posts

See All